EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Angiocrine Signaling in Sinusoidal Health and Disease

Shawna A Cooper, Enis Kostallari, Vijay H Shah

Seminars in Liver Disease · 01.08.2023 · 43 (03) · 245-257

DOI: 10.1055/a-2128-5907 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, erschienen am 01.08.2023. Verfasst von Shawna A Cooper und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Molecular Biology Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Hypertension, Portal. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, American Association for the Study of Liver Diseases, Gilead Research Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver sinusoidal endothelial cells (LSECs) are key players in maintaining hepatic homeostasis. They also play crucial roles during liver injury by communicating with liver cell types as well as immune cells and promoting portal hypertension, fibrosis, and inflammation. Cutting-edge technology, such as single cell and spatial transcriptomics, have revealed the existence of distinct LSEC subpopulations with a clear zonation in the liver. The signals released by LSECs are commonly called “angiocrine signaling.” In this review, we summarize the role of angiocrine signaling in health and disease, including zonation in healthy liver, regeneration, fibrosis, portal hypertension, nonalcoholic fatty liver disease, alcohol-associated liver disease, aging, drug-induced liver injury, and ischemia/reperfusion, as well as potential therapeutic advances. In conclusion, sinusoidal endotheliopathy is recognized in liver disease and promising preclinical studies are paving the path toward LSEC-specific pharmacotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseHypertension, PortalHumansEndothelial CellsLiverFibrosisLiver Cirrhosis

Autor:innen und Institutionen

  • Biochemistry and Molecular Biology Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota.
  • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Förderung

  • NIDDK NIH HHS
  • American Association for the Study of Liver Diseases
  • Gilead Research Scholars
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Cooper, S. A., Kostallari, E., & Shah, V. H. (2023). Angiocrine Signaling in Sinusoidal Health and Disease. Seminars in Liver Disease, 43(03), 245-257. https://doi.org/10.1055/a-2128-5907

Vancouver

Cooper SA, Kostallari E, Shah VH. Angiocrine Signaling in Sinusoidal Health and Disease. Seminars in Liver Disease. 2023;43(03):245-257. doi:10.1055/a-2128-5907

BibTeX
@article{Cooper2023,
  author = {Cooper, Shawna A and Kostallari, Enis and Shah, Vijay H},
  title = {Angiocrine Signaling in Sinusoidal Health and Disease},
  journal = {Seminars in Liver Disease},
  year = {2023},
  volume = {43},
  number = {03},
  pages = {245--257},
  doi = {10.1055/a-2128-5907}
}
Kostenlos starten →